FDA
- Status: approved
pegylated interferon alpha and plus ribavirin (pegylated interferon alpha and plus ribavirin) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Kaohsiung Medical University Chung-Ho Memorial Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.